Covaxin

Que. What is ‘Covaxin’ and how was it

developed?

 
The vaccine candidate was developed by BBIL in collaboration with the National Institute of Virology (NIV). NIV isolated a strain of the novel coronavirus from an asymptomatic Covid-19 patient and transferred it to BBIL early in May. The firm then used it to work on developing an “inactivated” vaccine — a vaccine that uses the dead virus — at its high-containment facility in Hyderabad.

“Once the vaccine is injected into a human, it has no potential to infect or replicate, since it is a killed virus. It just serves to the immune system as a dead virus and mounts an antibody response towards the virus,” said the company, adding that inactivated vaccines usually have a proven safety record.

Comments

Popular posts from this blog

Oxygen in ocean

Maximum"Oxygen" producer in Earth.

Recent droughts in Europe were the worst in 2,100 years.

The Smallest guitar

Carbon Cycle

Venus

How glaciers hold water